Learn More About COVID-19

The COVID-19 pandemic is creating a particularly challenging environment for healthcare professionals to deliver care to patients with existing health conditions such as diabetes.

WHO Statement

https://www.who.int/health-topics/coronavirus

WHO Q&A for the public

https://www.who.int/news-room/q-a-detail/q-a-coronaviruses

Maps

Repositories

BMJ https://www.bmj.com/coronavirus
Lancet Respiratory Medicine https://www.thelancet.com/coronavirus
NEJM https://www.nejm.org/coronavirus
JAMA https://jamanetwork.com/journals/jama/pages/coronavirus-alert

Privacy Policy | Website Terms and Conditions

Address for correspondence: ABCD (Diabetes Care) Ltd, 483 Green Lanes, London, N13 4BS

Telephone: 01675 477602 Email: info@abcd.care

ABCD (Diabetes Care) is a company limited by shares in England and Wales under company number 7270377, whose registered address is Sterling House, 1 Sheepscar Court, Meanwood Road, Leeds LS7 2BB. Diabetes Care Trust (ABCD) is a registered charity number 1139057, a company limited by guarantee in England and Wales under company number 74248361,whose registered address is Sterling House, 1 Sheepscar Court, Meanwood Road, Leeds LS7 2BB. ABCD (Diabetes Care) Ltd is a wholly owned subsidiary of the Diabetes Care Trust (ABCD) Ltd

ABCD Corporate Pharma Sponsors; Gold: Astra Zeneca, Lilly, Sanofi. Silver: A.Menarini Farmaceutica Internazionale SRL,

ABCD Corporate Pump & Device Supporters, Gold: Abbott Laboratories Ltd, Dexcom, GlucoRx, Insulet International Ltd, Ypsomed Ltd; Silver: Air Liquide Healthcare Ltd, Medtrum Ltd, Menarini Diagnostics; Bronze: Roche Diabetes Care.

Read the ABCD statement on pharmaceutical industry funding

Learn More About COVID-19

COVID-19 Links

Shared Resources

ABCD Webinar Series

Search form

You are here

Learn More About COVID-19

COVID-19 Links

Shared Resources

ABCD Webinar Series